Vivatides Therapeutics

HealthcareSeries AHong Kong, Hong Kong SAR - China

Latest round

Series A

Last raised

Apr 2026

Total raised

$64M

Investors

4

About Vivatides Therapeutics

Founded in 2025 and based in Hongkong, Vivatides Therapeutics Limited, dba Vivatides Therapeutics, is a biotechnology company developing extra-hepatic targeted small-nucleic-acid therapeutics. Vivatides Therapeutics is developing a preclinical extra-hepatic targeted oligonucleotide delivery platform and associated therapeutic pipelines (including both ASO and siRNA approaches) aimed at enabling targeted delivery beyond the liver. Public descriptions emphasize platform differentiation at the design level to overcome extra-hepatic delivery challenges.

Who invested in Vivatides Therapeutics

4 investors across 2 rounds

See all investors in Vivatides Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Apr 10, 2026

    Amount

    $54M

    Investors

    Locked

  2. Seed

    Aug 20, 2025

    Amount

    $10M

    Investors

    Locked

Questions about Vivatides Therapeutics

Who invested in Vivatides Therapeutics?

Vivatides Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Vivatides Therapeutics raised?

Vivatides Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Vivatides Therapeutics last raise money?

Vivatides Therapeutics's most recent round on record is a Series A, in Apr 2026.

What does Vivatides Therapeutics do?

Founded in 2025 and based in Hongkong, Vivatides Therapeutics Limited, dba Vivatides Therapeutics, is a biotechnology company developing extra-hepatic targeted small-nucleic-acid therapeutics.

Where is Vivatides Therapeutics headquartered?

Vivatides Therapeutics is headquartered in Hong Kong, Hong Kong SAR - China.

Which VCs invest in companies like Vivatides Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Shanghai State-owned Capital Investment Leading Fund and Yufu Capital back healthcare companies at Vivatides Therapeutics's stage. Their profiles are linked below.

Raising like Vivatides Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.